Pregnancy is associated with a progressive remodeling of the uterine artery. This adaptation is influenced by local and systemic pregnancy-dependent factors. We recently demonstrated that the peptide hormone relaxin mediates uterine artery remodeling in late pregnant rats. The objective of this study in relaxin gene knockout (Rln À/À ) mice was to test the hypothesis that relaxin deficiency throughout pregnancy disrupts uterine artery remodeling, an effect that is exacerbated by aging and reversed with relaxin treatment. Passive mechanical wall properties and extracellular matrix components were measured using pressure myography, quantitative PCR, and zymography in uterine arteries from pregnant wild-type (Rln +/+ ) and Rln À/À mice aged 5 and 8 mo on Days 12.5 and 17.5 pregnancy. In a second study, 8-mo-old Rln À/À mice received either placebo or human recombinant relaxin subcutaneously for 5 days from Day 12.5 pregnancy. Relaxin deficiency in pregnancy did not alter uterine artery remodeling in young mice. However, remodeling was impaired in older pregnant Rln À/À mice, resulting in significantly stiffer uterine arteries. Uterine arteries of aged Rln À/À pregnant mice had increased expression of elastin, whereas several matrix metalloproteinases and cell adhesion molecules were decreased relative to Rln +/+ mice. Fetal weight was also significantly reduced in Rln À/À mice in late pregnancy in both young and old dams, whereas placental weight was unchanged. Arterial stiffness and reduced fetal weight were reversed after relaxin treatment. In conclusion, relaxin deficiency compromises uterine artery remodeling in older pregnant females, increasing the risk of pregnancy complications such as hypertension and intrauterine growth restriction.
INTRODUCTION
Pregnancy is associated with dramatic modifications to the maternal uteroplacental vasculature to increase uterine blood flow and meet the nutritional demands of the growing fetus. This is achieved through a profound decrease in uterine vascular resistance and structural remodeling of the uterine artery wall [1, 2] . Failure of these changes to occur reduces uteroplacental perfusion and contributes to pregnancy complications such as gestational hypertension and intrauterine growth restriction [3] [4] [5] .
Structural modifications of the uterine artery occur in two phases. Initially, there is outward hypertrophic remodeling of the arterial wall, attributed to vascular smooth muscle cell (VSMC) dedifferentiation and proliferation in the tunica media [6] . The artery lumen diameter widens throughout pregnancy without significant thickening of the vessel wall. Uterine and radial arteries also become longer and more distensible in both axial and radial directions [7] . Maximum remodeling of the main uterine artery occurs during late pregnancy and is associated with VSMC hypertrophy and hyperplasia [7] [8] [9] [10] . This remodeling coincides with changes in the biomechanical properties of the artery, with arterial compliance changing as pregnancy advances [2] . Although there are considerable species differences, these biomechanical changes are attributed to alterations in the composition of the uterine artery wall. In sheep and pigs, there is a reduction in collagen content with no change in elastin [9, 10] . In contrast, the density of collagen and elastin in the uterine arteries of mice is not altered by pregnancy [6, 11, 12] . It has been suggested that degradation of the vessel wall extracellular matrix (ECM) may occur, enabling cell movement and tissue reorganization. Matrix metalloproteinase (MMP) expression and MMP2 activity are increased in the rat uterine artery in late pregnancy and are likely to play an important role in ECM reorganization [13, 14] .
The factors responsible for the remodeling of the uterine vasculature during pregnancy, particularly the main uterine artery, are influenced by a combination of local and systemic pregnancy-dependent factors [2, 15] . Studies using pseudopregnant mice demonstrated that the conceptus is not involved in the initial remodeling response of the uterine artery [11] , but as pregnancy progresses, the fetoplacental unit plays a major role in mediating expansion of the uteroplacental vasculature [16, 17] . Shear stress resulting from an increase in blood flow velocity and estrogen both induce uterine artery remodeling by upregulating endothelial nitric oxide synthase (NOS3) [18, 19] . Uterine artery remodeling is substantially impaired, but not absent, in pregnant Nos3 knockout mice [6] and in pregnant rats treated with a NOS inhibitor, L-NAME [14, 20] . In pregnant NO-compromised rats, collagen and elastin content in the vessel wall is significantly increased, with a reduction in MMP expression and tissue inhibitors of MMP (TIMPs) [14] . Increasing maternal age also is associated with reduced uterine artery remodeling in pregnancy and coincides with poor pregnancy outcome [11] .
We recently demonstrated that the peptide hormone relaxin increases uterine blood flow velocity and mediates uterine artery remodeling in late pregnancy rats [21] . Receptors for relaxin are localized predominantly in the VSMCs in the rat uterine artery, and administration of a monoclonal antibody (MCA1) to neutralize circulating rat relaxin for 3 days at the end of pregnancy resulted in increased uterine artery stiffness [21] . However, there was no effect of relaxin-deficiency on collagen or elastin content in the tunica media. Nor was there any change in the mRNA expression of gelatinases (Mmp2 and Mmp9) or their inhibitors (Timp-1 or -2). We argued that infusion of MCA1 for 3 days was not sufficient to produce changes in fibrillar collagens or elastin or that the impact of relaxin deficiency on vessel wall collagen may be more pronounced in the context of disease rather than healthy physiological states. This hypothesis is supported by studies in male and nonpregnant (NP) female relaxin gene knockout mice (Rln À/À ), which showed that small renal arteries had reduced passive compliance and were stiffer and that this was associated with a decrease in VSMC density and increased collagen [22, 23] . Treatment of Rln À/À mice with relaxin reversed these phenotypes, most notably increased compliance mediated by both geometric (outward) and compositional (decreased collagen) remodeling [23] . The Rln À/À mice in these studies were between 3 and 7 mo old so it is possible that the vascular phenotypes were augmented in the older mice. We therefore tested the hypothesis in Rln À/À mice that relaxin deficiency throughout pregnancy disrupts uterine artery remodeling through modifications to the ECM, effects that are exacerbated by ageing. The main objectives were to determine whether passive mechanical wall properties in the uterine artery are impaired in pregnant Rln À/À mice aged 5 and 8 mo, and if so, investigate the molecular pathways involved.
MATERIALS AND METHODS

Animals
All the animal experiments were approved by The University of Melbourne Animal Experimental Ethics Committee (AEEC no. 0911478.1) and conducted in accordance with the Australian Code of Practice and the National Health and Medical Research Council and the Society for the Study of Reproduction guidelines. This study used the original Rln À/À mouse [24] backcrossed on a C57/BLK6J background to the F 14 generation and wild-type littermates (Rln þ/þ ) of the same strain. Genotypes were confirmed by PCR analysis of genomic DNA from ear clips as previously described [24] . The mice were housed in the Department of Zoology Animal House Facilities (University of Melbourne) in a 12L:12D cycle at 208C, with standard food pellets (Barastock) and water provided ad libitum.
To investigate the effects of relaxin deficiency throughout pregnancy and the effects of aging, Rln þ/þ and Rln À/À mice were studied at 1) 5 mo (average 4.88 6 0.09 mo) and 2) 8 mo (average 7.91 6 0.06 mo). At 8 mo of age, we consider the mouse to be at the latter stage of their reproductive life cycle. Primigravid females were then mated with males of matching genotypes to obtain timed pregnancies. If a copulation plug was found the next morning, this was designated as Day 0.5 pregnancy. Delivery at term typically occurs between Days 19 and 19.5 pregnancy [25] . The mice were killed by isofluorane overdose and cervical dislocation on Days 12.5 and 17.5 pregnancy in 5-mo-old mice and Day 17.5 pregnancy in 8-mo-old mice (n ¼ 8 per group). Only one time point was assessed in the older mice due to the difficulty in obtaining successful matings and pregnancies because they were near the end of their reproductive life cycle. A fourth group of 5-mo-old NP mice were also studied; these animals were in estrus as confirmed by vaginal smear (n ¼ 8 per group). Maternal and fetal body weights, and litter size, were measured directly after dissection on Day 17.5 pregnancy in 8-mo-old mice. Only viable fetuses were included in the weight assessment. The total weight of the litter was divided by the number of fetuses to obtain average individual fetal body weight. Fetal body weights and litter size on Day 18.5 pregnancy were also obtained from dams aged between 3 and 6 mo from studies in our laboratory over the previous 5 yr (n ¼ 7 per group). The main right uterine artery was dissected from the surrounding fat and placed in ice-cold Ca 2þ -free, 2 mM ethylene glycol tetraacetic acid (EGTA) containing physiological saline solution for analysis of passive mechanical wall properties. The left uterine artery was dissected and frozen in liquid nitrogen before storage at À808C for later molecular analysis.
To test the effects of exogenous relaxin treatment on arterial remodeling, 8-mo-old female Rln À/À mice were surgically implanted with Alzet osmotic minipumps (Model 1007D, flow rate: 0.5 ll/h; BioScientific Pty Ltd) on Day 12.5 pregnancy to administer 3.33 lg/h/kg recombinant human H2 relaxin (rhRLX) (Corthera Inc.) or placebo (n ¼ 6 per group). This dose and duration of rhRLX prevents dystocia in pregnant Rln À/À mice but does not induce premature birth [25] . This dose was predicted to yield concentrations of circulating relaxin similar to those measured on Day 18 pregnancy in mice [26] . Uterine arteries were collected on Day 17.5 pregnancy as described above. Fetal weights and litter size on Day 18.5 pregnancy were also obtained from dams aged between 3 and 6 mo, from studies in our laboratory over the previous 5 yr in which dams received either placebo or rhRLX (n ¼ 5 per group). In addition, blood was collected by cardiac puncture to measure serum rhRLX concentrations using the Quantikine human H2 ELISA kit (R&D Systems Inc.) according to the manufacturer's instructions. Mouse plasma was diluted 1:250 with the Calibrator Diluent RD6-6 to obtain measurements in the linear range of the standard curve rhRLX standards (7.8-500 pg/ml). All the samples were assayed on a single ELISA plate, and the limit of detection was 15.6 pg/ml.
Arterial Passive Mechanical Wall Properties
Uterine arteries were transferred and stored for 30 min in 2 mM Ca 2þ -free EGTA containing physiological saline solution (PSS): 142 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 0.5 mM ethylenediaminetetraacetic acid (EDTA), 10 mM HEPES, 1.7 mM MgSO 4 , and 5 mM glucose. Leak-free segments of artery (2-3 mm in length) were mounted on a glass microcannula (80-125 lm in outside diameter) of a pressure myograph (Living Systems Instrumentation) filled with Ca 2þ -free EGTA-PSS. The free distal end of the artery was tied off to prevent flow. After a 20 min equilibration period in warmed (368C) Ca 2þ -free EGTA-PSS, arteries were pressurized from 0 to 200 mmHg, in 10 mmHg increments. The vessel length, outside diameter (OD) and wall thickness (WT) were measured at each increment. Inside diameter (ID) was calculated by subtracting the WT from the OD. Wall thickness-to-lumen ratio was derived from the following calculation: WT/ID. Wall stress and strain were derived from the following calculations: wall stress (kPa)
; wall strain ¼ (ID À ID extrapolated to 5 mmHg pressure)/(ID extrapolated to 5 mmHg pressure) [27, 28] . For normalization of ID and OD, the values were expressed as (value at pressure À value at 5 mmHg)/(value at 5 mmHg).
Uterine Artery Gene Expression
Total RNA was extracted from uterine arteries of the 8-mo-old pregnant females, using TRI Reagent (Ambion) and a Digital Wig-L-Bug amalgamator (Dentsply Ltd) as previously described [21, 22] . RNA concentrations were measured using the NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Inc.). First strand cDNA synthesis was performed using 500 ng total RNA in a 20 ll reaction with random hexamers (50 ng/ll) and 200 units SuperScript III (Invitrogen). All the RNA samples were reverse transcribed simultaneously to avoid variation during cDNA synthesis. Expression of collagen type I (Col1a1), collagen type III (Col3a1), elastin (Eln) and relaxin receptor (Rxfp1) was assessed by quantitative PCR (QPCR) using the À2
DCT method with ribosomal 18S (Rn18s) as the endogenous reference gene. Mouse-specific oligonucleotide primers and 6-carboxy fluorescent-labeled TaqMan probes (BioSearch Technologies, Inc.) were designed to span an exon/intron junction to avoid genomic DNA contamination using the Primer 3 software. Primer and probe sequences are listed in Supplemental Table S1 (Supplemental Tables are available online 
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Quantitative PCR Arrays
The mouse Extracellular Matrix and Adhesion Molecules QPCR array (SuperArray Biosciences) was used to screen the expression of 84 genes associated with the ECM and cell adhesion molecules in individual uterine arteries from both genotypes of 8-mo-old mice (n ¼ 5 arrays per group). In brief, cDNA was synthesized from 500 ng total RNA using the RT2 PCR array First Strand Kit (SABiosciences), and the PCR reactions used the RT2 SYBR Green qPCR Master Mix on the Opticon 2 PCR platform according to the manufacturer's instructions. Data were analyzed using the 2
ÀDCt method with normalization of the raw data to the average of three reference genes (B2m, Hprt1, and Actb).
Zymography
Uterine artery gelatinase activity was measured in 8-mo-old Rln þ/þ and Rln À/À by zymography as previously described with minor modifications [29, 30] . Briefly, frozen uterine arteries were pulverized using a WIG-L-BUG amalgamator (Dentsply Ltd) and homogenized in five volumes of protein extraction buffer (10 mM Tris, pH 6.8, 7 M urea, 10% glycerol, 1% SDS). The homogenate was centrifuged at 15 000 3 g for 10 min at 48C, and the protein concentration of the supernatant was determined in triplicate using the Pierce BCA Protein Assay Kit (Thermo Scientific). Ten micrograms of protein was combined with an equal volume of 23 Zymogram Sample Buffer (Bio-Rad) and electrophoresed on precast Ready Zymogram Gels (10% gelatin; Bio-Rad) for approximately 2 h at 100 V. Gels were then incubated in Zymogram Renaturation Buffer (Bio-Rad) for 3 h followed by Zymogram Development Buffer for 30 min, both at room temperature with gentle agitation. The buffer was then replaced with fresh Development Buffer and gels were incubated at 378C for approximately 14 days. Staining and destaining of gels was performed with gentle agitation at room temperature, using fresh 0.5% Brilliant Blue R250 in 30% methanol and 10% acetic acid for 4 h. Further destaining took place in 1% Triton X-100 for 1 h, after which the gels were imaged using the ChemiDoc XRS Imaging System. Individual gelatinase bands were quantified using Quantity One Image software (Bio-Rad).
Statistical Analysis
All the data are expressed as mean 6 SEM (n ¼ the number of animals). The strain component of the stress-strain relationships, OD, ID, and WT was analyzed using a two-way repeated measures ANOVA (genotype or age vs. strain), with Bonferroni post hoc analysis (GraphPad Software Inc.). The DC T data from the QPCR of target genes and Rn18s were all normally distributed within groups (SPSS Inc., version 17). Fetal and placental weight was derived from the average weight of each litter. Statistical differences in gene expression and fetal and placental weights between Rln þ/þ and Rln À/À mice were analyzed using independent t-tests (SPSS Inc., version 17). All the statistical analysis was at the 95% confidence level.
RESULTS
Uterine Artery Structure and Passive Mechanical Wall Properties
In uterine arteries at rest (5 mmHg), OD, ID, and WT were significantly (P , 0.05) increased in Days 12.5 and 17.5 (Fig. 1A and Table 1 ). When the arteries were pressurized, the OD (normalized to diameter at 5 mmHg) of pregnant mice increased to a greater extent (P , 0.05) than those from NP Rln þ/þ mice (Fig. 1B) . Normalized ID was significantly increased in Day 12.5 pregnant Rln þ/þ mice compared with NP Rln þ/þ mice (P , 0.05). However, there was no change in normalized ID in Day 17.5 pregnant Rln þ/þ mice (Fig. 1C) . There was no change in WT (data not shown). Although wall thickness-to-lumen ratio was not affected by pregnancy, it was significantly (P , 0.05) decreased at physiological pressures (60 mmHg) on Day 12.5 pregnancy compared to NP mice. This decrease was not observed on Day 17.5 pregnancy ( Table 1 ). The stress-strain curves for uterine arteries of the pregnant mice were shifted to the right compared to those of their NP counterparts (P , 0.05; Fig. 1D ), indicating decreased wall stiffness.
IMPAIRED UTERINE ARTERY REMODELING IN
The resting OD of uterine arteries of NP Rln À/À mice was significantly (P , 0.05) larger than NP Rln þ/þ mice. With pregnancy, resting OD, ID, or WT did not increase to the same extent as for arteries from Rln þ/þ mice ( Table 1 ). Similar observations were also made at physiological pressures (Table 1) . When pressurized, the OD and ID (absolute and normalized to diameters at 5 mmHg) of uterine arteries from Days 12.5 and 17.5 pregnant Rln À/À mice did not differ significantly from Rln þ/þ mice (Table 1 and Fig. 2 , A, C, and E). There was also no change in normalized WT with pressurization between arteries from Rln À/À and Rln þ/þ mice (data not shown). Arterial stiffness was not significantly different in uterine arteries in NP Rln À/À mice or on Days 12.5 and 17.5 pregnancy compared with arteries of Rln þ/þ mice (Fig. 3 , A-C). In the older Rln þ/þ mice aged 8 mo, resting and physiological OD, ID, and WT were not significantly different compared with the dimensions of the uterine artery of 5-mo-old Rln þ/þ mice on Day 17.5 pregnancy (Table 1) . With pressurization, all of these dimensions were not different between mice from 5 and 8 mo of age (Table 1) . At rest and at 60 mmHg, uterine artery OD, ID, WT, and wall-to-lumen ratio were also not significantly different in 8-mo-old Rln À/À mice compared with Rln þ/þ mice (Table 1) . Over the pressurization range, absolute OD was significantly increased in Rln À/À mice compared with Rln þ/þ mice (Fig. 2B) . However, when OD and ID were normalized, arteries from 8-mo-old Rln À/À mice were not able to increase to the same extent as arteries from Rln þ/þ mice (P , 0.05; Fig. 2, D and F) , with no significant effect on normalized WT. Increased maternal age had no effect on arterial stiffness on Day 17.5 pregnancy as the stress-strain curves did not differ significantly between the 8-mo-old Rln þ/þ mice and the 5-mo-old Rln þ/þ mice (data not shown). However, the uterine artery was markedly stiffer in 8-mo-old Rln À/À mice compared with Rln þ/þ mice of the same age, as indicated by a significant leftward shift of the stress-strain curve (F 1152 ¼ 6.56; P , 0.05) (Fig. 3D) .
QPCR Analysis of Vascular ECM and Adhesion Molecules
Given the marked differences in wall stiffness of the uterine artery between 8-mo-old pregnant Rln À/À and Rln þ/þ mice, we focused our molecular analysis on arteries from this age group. Conventional QPCR demonstrated there was no significant effect of relaxin deficiency on Col1a1 and Col3a1 expression in the uterine artery on Day 17.5 pregnancy (Fig. 4, A and B) . However, Eln expression in Rln À/À mice was significantly (t 9 ¼ 3.09; P , 0.01) higher compared to Rln þ/þ mice (Fig. 4C) . Uterine artery expression of Rxfp1 did not differ significantly 
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between Rln À/À and Rln þ/þ mice on Day 17.5 pregnancy (Fig.  4D) .
We then screened a broader range of ECM and adhesion molecules through the use of arrays. The expression of each screened gene was corrected against the arithmetic mean of three reference genes (B2m, Hprt1, and Actb). All 84 genes on the array were expressed in the uterine artery of late pregnancy mice (average raw C T 29.78; Supplementary Table S2) . Expression was ranked from highest to lowest levels, and those genes that displayed .2.5-fold difference between Rln þ/þ and Rln À/À mice are shown in Table 2 . A total of 19 genes were expressed at lower levels in the uterine artery of Day 17.5 pregnant Rln À/À mice compared with Rln þ/þ mice, and seven of these reached significance (P , 0.05; n ¼ 3 arrays). These include Mmp2, Mmp10, Mmp14, Tgfb1, and Itga6 (Fig. 4, E-I ). There was no significant change in any of the 11 collagen genes examined (Supplementary Table S2 ). 
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Analysis of Vascular Gelatinase Activity
We then investigated if the reduction in Mmp2 gene expression was correlated with altered pro-MMP2 protein and MMP activity in main uterine arteries of 8-mo-old Rln À/À mice on Day 17.5 pregnancy. There was a significant (Fig. 5 , A and B; P , 0.05) reduction in pro-MMP2 protein in the uterine arteries of Rln À/À mice compared with Rln þ/þ mice, but there was no difference in active MMP-2 (Fig. 5C) .
Effects of Relaxin Deficiency on Fetal and Placental Growth
Fetal weights were significantly (13%; P , 0.01) reduced in 8-mo-old Rln À/À dams on Day 17.5 pregnancy mice compared with Rln þ/þ mice (Fig. 6A ), but there was no difference in placental weight (in g; Rln þ/þ ¼ 0.138 6 0.005; Rln À/À ¼ 0.137 6 0.005). This finding was also observed in retrospective analysis of fetal (14% reduction) and placental weights collected on Day 18.5 pregnancy in Rln À/À mice aged between 3 and 6 mo (Fig. 6B) .
Effects of rhRLX Treatment on Arterial Remodeling
Treatment with rhRLX for 5 days in pregnant 8-mo-old Rln À/À mice resulted in serum rhRLX concentrations of 4.85 6 0.23 ng/ml, which is equivalent to serum relaxin concentrations measured in late pregnant mice [26] . This had no significant effect on uterine artery OD, ID, WT, and wall-to-lumen ratio at rest or at 60 mmHg on Day 17.5 pregnancy (Table 1) . Over the pressurization range, there was no difference in absolute OD (Fig. 7A) . However, normalized OD and ID in rhRLX-treated mice increased to a significantly (P , 0.05) greater extent compared with placebo controls (Fig. 7 , B and C), with no effect on normalized WT (data not shown). Treatment with rhRLX in Rln À/À mice also resulted in a significant (P , 0.05) shift of the stress-strain curve to the right compared to untreated Rln À/À mice, indicating decreased stiffness of the uterine artery, restoring it to values in Rln þ/þ mice (Fig. 7D ). In addition, fetal weight of 3-6-mo-old pregnant Rln À/À mice treated with rhRLX was significantly increased compared to placebo controls, restoring fetal weight to in Rln þ/þ levels (Fig.  7E) .
DISCUSSION
The key finding of this study was that relaxin has protective effects on the uterine vasculature in older pregnant mice. Specifically, uterine arteries from 8-mo-old pregnant Rln À/À mice were markedly stiffer compared with those from Rln þ/þ mice. We also identified significant changes in Mmp, Tgfb1, Itga6, and Eln expression in the arteries of Rln À/À mice but no increase in a broad range of collagen genes. Reduction in Mmp2 expression was translated into reduced pro-MMP-2 but not active MMP2. This suggests that the increased arterial stiffness in Rln À/À mice is unlikely due to increased collagen synthesis in the vessel wall but may be associated with disruption to other ECM components and/or cell adhesion. The enhanced stiffness of the uterine artery of 8-mo-old pregnant Rln À/À mice was alleviated following 5 days of treatment with GOOI ET AL. DCt method (n ¼ 6 group). Expression of (E) Tgfb, (F) Mmp2, (G) Mmp10, (H) Mmp14, and (I) Itga6 are normalized to the average of three reference genes (B2m, Hprt1, and Actb) using the 2 ÀDCt method (n ¼ 5 per group). All the data are mean 6 SEM. Differs significantly compared with Rln þ/þ mice (*P , 0.05, **P , 0.01). 
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À/À MICE exogenous relaxin. Overall, these findings demonstrate that relaxin contributes to the regulation of the passive mechanical properties of the uterine artery in pregnancy, and its importance in this role increases with maternal aging. The highest circulating concentrations of relaxin occur during mid-to late pregnancy in rodents [31] , and treatment of midpregnant rats with the MCA1 relaxin-neutralizing antibody prevents the pregnancy-associated decrease in myogenic reactivity in small renal arteries [32] , demonstrating a role for relaxin as a vasodilator during pregnancy. These relaxincompromised rats also fail to exhibit the gestational decreases in systemic vascular resistance and increases in stroke volume, cardiac output or global arterial compliance that occur in control pregnant rats [33] . Nonpregnant Rln À/À mice deficient in endogenous relaxin show similar vasodilatory phenotypes, notably reduced myogenic reactivity in the small renal arteries [22] . However, few studies have investigated the impact of relaxin deficiency during pregnancy on arterial remodeling and compliance. We previously reported that uterine artery remodeling and passive mechanical wall properties are compromised in late pregnant rats treated for 3 days with MCA1 [21] . This is in contrast to our data in pregnant Rln À/À mice aged 5 mo in which there was no effect of relaxin deficiency on uterine artery remodeling in either midpregnancy (Day 12.5) or late pregnancy (Day 17.5). A likely explanation is that other factors such as estrogen or local fetal influences are more important than relaxin to ensure normal uterine artery remodeling in the younger Rln À/À mice [16] [17] [18] . Estrogens have a direct acute vasorelaxant effect on rat uterine arteries [34] and increase local nitric oxide production either by inhibiting nitric oxide degradation [35] or enhancing endothelial nitric oxide synthase activity [36] . It is possible that in the young Rln À/À mouse estrogen has a protective effect on arterial function by mediating active tone and passive stiffness. However, in the older Rln À/À mice, with falling estrogen levels these mechanisms do not operate at full efficiency and therefore the detrimental effect of relaxin deficiency on passive stiffness is revealed. Consistent with this, it has been reported that estrogen replacement in 10-mo-old rats reduces passive stiffness in mesenteric arteries [37] . It is interesting to note that the resting passive OD of the uterine artery was larger in NP
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À/À mice compared with Rln þ/þ , suggesting some modification to the uterine artery in response to relaxin deficiency. These modifications were not due to a previous pregnancy because all the NP mice were primigravid. The appearance of vascular phenotypes in the uterine arteries of older Rln À/À mice was not due simply to aging because there were no differences in passive mechanical wall properties between the 5-and 8-moold Rln þ/þ mice on Day 17.5 pregnancy. Therefore, we conclude that relaxin deficiency in the older mice results in structural modifications and increased stiffness in the uterine artery. This, together with a depletion in the reserves of other mechanisms, such as those influenced by estrogen and/or nitric oxide [38] that normally ensure adequate adaptation of the uterine artery, may exacerbate the effects of relaxin deficiency in older animals.
It was important to consider the potential effects of relaxin deficiency on litter size given the known local stretch effects of fetuses in utero on uterine artery remodeling [16, 17] . Litter sizes are not significantly reduced in younger Rln À/À [24, 25] or older Rln À/À C57/Bl6J mice so the remodeling phenotype is not due to a reduction in the local signaling influence of the fetuses. In our study, fetal weight was significantly reduced in late pregnancy in mothers aged 3-6 mo and 8 mo, which suggests that fetal growth is impaired in Rln À/À mice. This might be due to reduced blood flow through a less compliant uterine artery and consequently poor uteroplacental perfusion. However, placental weights were not compromised in Rln À/À mice. It is possible that a compensatory adjustment has occurred in the placenta, but this generally involves alterations in placental nutrient transport to maintain fetal growth [39] . Further analysis of placental structure, function, and nutrient delivery is required to understand mechanisms of fetal growth restriction in Rln À/À mice. In addition, we cannot discount as yet unknown developmental differences between the Rln À/À and Rln þ/þ pups. Differential effects of relaxin deficiency on arterial passive compliance in rats and mice have been reported previously. There was no significant effect of treating midpregnant rats with the MCA1 antibody for 8 days on passive compliance in the small renal and mesenteric arteries [32] . In contrast, small renal arteries from male Rln À/À mice aged 4-6 mo were less compliant than those of wild-type males [22] . Interestingly, there were no phenotypic differences in passive mechanical wall properties in the external iliac artery [23] , which suggests that some arteries may be more susceptible to relaxin deficiency than others and under specific physiological GOOI ET AL.
conditions such as pregnancy or aging. Our studies in pregnant Rln À/À mice focused on the main branch of the uterine artery, which is a muscular vessel. It would be important to assess arterial remodeling and passive mechanical wall properties in another vascular bed, such as the mesenteric, to establish if the lack of a response to relaxin deficiency in uterine arteries of pregnant Rln À/À mice is artery specific or attributed to compensatory pregnancy factors. It has been hypothesized that other hormones produced during pregnancy may influence global arterial compliance if relaxin is absent in rats [33] .
Very little is known about the molecular mechanisms of relaxin deficiency on vascular wall remodeling. Small renal arteries of NP Rln À/À mice have smaller wall-to-lumen area ratios, associated with a decrease in VSMC density [23] . This suggests that relaxin deficiency compromises outward geometric remodeling. In our study, the uterine arteries of aged pregnant Rln À/À mice have reduced ID and OD when , and relaxin-treated Rln À/À on Day 18.5 pregnant mice (n ¼ 5 per group). Differs significantly compared with Rln þ/þ mice (*P , 0.05, **P , 0.01); differs significantly compared with relaxin-treated Rln À/À mice ( P , 0.05 and P , 0.01).
IMPAIRED UTERINE ARTERY REMODELING IN Rln À/À MICE pressurized, but there was no significant change in WT or wallto-lumen ratios. Our interpretation is that increased stiffness in the uterine arteries of pregnant Rln À/À mice is not due to impaired geometric remodeling. We also explored the possibility that relaxin deficiency results in increased collagen expression in the vessel wall as reported previously in small renal arteries [23] and numerous other tissues [40] [41] [42] . However, as we showed in the uterine arteries of MCA1-treated pregnant rats [21] , there is no evidence of increased collagen expression in the uterine arteries of aged pregnant Rln À/À mice. Analysis of other ECM components demonstrated that Eln expression was significantly increased in the uterine arteries of older Rln À/À mice compared with Rln
mice. There are conflicting views on changes in uterine artery elastin content during pregnancy. Some reports show a slight decrease in elastin content during pregnancy whereas others show elastin is unchanged, despite decreased uterine artery stiffness [9, 11] . It has been suggested that decreases in elastin reduce elastic recoil and thus enhance distensibility in the rat uterine vein during pregnancy [43] . Therefore, if increased Eln expression in Rln À/À mice reflects increased elastin content in the vessel wall, and the nature of the elastin is stiffer, this could contribute to reduced distensibility. Indeed, increased deposition of abnormally organized elastin causes arterial stiffening in prehypertensive, spontaneously hypertensive rats [44] .
In order to maximize experimental usage of collected uterine arteries, we chose a QPCR array analysis approach to assess how relaxin deficiency might affect other ECM and cell adhesion molecules in the uterine arteries of aged Rln À/À mice. This allowed us to screen a broad range of ECM genes, which could not be achieved through quantitative histology. A total of 19 genes were expressed at lower levels in the uterine artery of Day 17.5 pregnant Rln À/À mice compared with Rln þ/þ mice. The most significant changes were reductions in Mmp2, Mmp10, Mmp14, Tgfb1, and Itga6 as well as modest decreases in other integrins and laminin 2 expression in the uterine artery of Day 17.5 pregnant Rln À/À mice compared with Rln þ/þ mice. A decrease in arterial wall MMP expression due to relaxin deficiency has not been demonstrated previously. The reduction in Mmp2 expression translated into decreased pro-MMP-2, which confirms previous observations of decreased gelatinase expression and activity in other tissues of Rln À/À mice [30, 45] . A reduction in MMP2 expression in NOcompromised pregnant rats is also associated with a significant increase in collagen and elastin content in the uterine artery [14] . Based on these findings, we suggest that impaired MMP expression in the uterine artery of aged pregnant Rln À/À mice could affect the organization and/or cross-linking of collagen and elastin in the ECM. However, it is important to note that the uterine artery is a resistance artery so changes to the ECM may contribute less to the passive stiffness of the vessel especially in younger mice.
The effects of decreased Tgfb1 and integrin expression on the ECM in the uterine arteries of Rln À/À mice are unclear. Several subsets of the abl and ab3 integrins mediate binding of cells to collagen, fibronectin, and vitronectin, and are upregulated by TGFb [46] . In vitro studies show that TGFb1 mediates actions associated with vessel remodeling and stability including inhibition of endothelial cell proliferation and migration and production of basement membrane [47, 48] . Therefore, a decrease in TGFb1 expression in Rln À/À mice could directly or indirectly, through integrins, affect the ability of cells to adhere to different components of the ECM and alter the organization of the ECM.
The final part of this study demonstrated that chronic subcutaneous infusion of relaxin for 5 days in aged pregnant Rln À/À mice reversed the vascular phenotype and reduced uterine artery stiffness as well as restored fetal weight to Rln þ/þ levels. This action of relaxin has been reported in several studies in male and NP female rats, in a variety of conduit and resistance arteries [26, [49] [50] [51] [52] . Our data in pregnant mice are similar to that reported in the small renal arteries of relaxintreated, NP female Rln À/À using a dose of approximately 1 lg/h rhRLX [23] . The serum rhRLX levels achieved with this dose are equivalent to serum concentrations of endogenous mouse relaxin in late pregnancy [53] . In our study, treatment with rhRLX in Rln À/À mice increased OD and ID but had no significant effect on WT or the wall-to-lumen ratio. Debrah et al. [23] also showed that relaxin treatment in Rln À/À mice increased unstressed wall lumen area, wall-to-lumen ratio, and VSMC density in small renal arteries but had little effect on the iliac arteries. Together, these two studies suggest that exogenous relaxin mediates remodeling of the uterine artery wall through compositional changes in the ECM.
In summary, this study demonstrated that uterine artery remodeling and passive mechanical wall properties in pregnant Rln À/À mice were only impaired in older animals. This phenotype was alleviated after 5 days of relaxin treatment. We suggest that other pregnancy-related factors compensate for the effects of relaxin deficiency in younger Rln À/À mice to ensure normal uterine artery remodeling. The increased arterial stiffness in older Rln À/À mice is likely associated with decreased MMP expression, increased elastin expression, and a disruption to the organization of the ECM within the vessel wall. TGFb1 and integrin expression were also decreased in Rln À/À mice, which might contribute to increased arterial stiffness through modifications to cell adhesion. We conclude that in aging females, relaxin plays an increasingly important role to ensure the normal structural adaptations of the uterine artery to pregnancy and allow for normal fetal growth.
